Woodline Partners LP Erasca, Inc. Transaction History
Woodline Partners LP
- $13.5 Billion
- Q4 2024
A detailed history of Woodline Partners LP transactions in Erasca, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 4,147,275 shares of ERAS stock, worth $6.51 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
4,147,275
Previous 4,138,849
0.2%
Holding current value
$6.51 Million
Previous $11.3 Million
7.88%
% of portfolio
0.08%
Previous 0.1%
Shares
10 transactions
Others Institutions Holding ERAS
# of Institutions
153Shares Held
221MCall Options Held
10.1KPut Options Held
79.3K-
Frazier Life Sciences Management, L.P. Menlo Park, CA19.4MShares$30.4 Million2.85% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.7MShares$26.2 Million0.03% of portfolio
-
Vr Adviser, LLC New York, NY16.2MShares$25.5 Million6.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$19.9 Million0.0% of portfolio
-
Logos Global Management LP San Francisco, CA12.5MShares$19.6 Million4.12% of portfolio
About Erasca, Inc.
- Ticker ERAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,147,000
- Market Cap $192M
- Description
- Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...